Boston Scientific Corporation BSX
NYSE
Recommendation
Dividend Power Score
Day's Range
$41.92$43.23
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.50B | 3.67B | 3.57B | 2.90B | 2.79B |
| Total Depreciation and Amortization | 1.43B | 1.41B | 1.39B | 1.37B | 1.35B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 84.00M | 84.00M | -135.00M | 514.00M | 561.00M |
| Change in Net Operating Assets | -784.00M | -642.00M | -483.00M | -246.00M | -77.00M |
| Cash from Operations | 4.23B | 4.53B | 4.34B | 4.53B | 4.63B |
| Capital Expenditure | -903.00M | -904.00M | -866.00M | -876.00M | -802.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.02B | -1.06B | -1.88B | -1.59B | -4.92B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.57B | -1.59B | 12.00M | -171.00M | -108.00M |
| Cash from Investing | -3.50B | -3.56B | -2.73B | -2.64B | -5.83B |
| Total Debt Issued | 1.00B | 1.67B | 0.00 | 1.56B | 1.75B |
| Total Debt Repaid | -481.00M | -696.00M | -997.00M | -2.05B | -1.84B |
| Issuance of Common Stock | 201.00M | 221.00M | 248.00M | 282.00M | 290.00M |
| Repurchase of Common Stock | -2.00B | -2.00B | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -146.00M | -157.00M | -139.00M | -186.00M | -192.00M |
| Cash from Financing | -1.42B | -958.00M | -888.00M | -395.00M | 3.00M |
| Foreign Exchange rate Adjustments | 6.00M | 2.00M | 3.00M | 42.00M | 30.00M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -1.00M | -- | -1.00M |
| Net Change in Cash | -679.00M | 12.00M | 724.00M | 1.54B | -1.17B |